Global Spinal Cord Stimulation (SCS) Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2019 is about 69%, and the proportion is in increasing trend from 2015 to 2019.
Spinal cord stimulation devices are widely used in Hospitals and Ambulatory Surgery Centers. The most proportion of spinal cord stimulation devices is used in Hospitals, and the proportion in 2019 is 71%.
North America is the largest consumption place, with a consumption market share nearly 57.7% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Market competition is intense. Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro, Nuvectra are the leaders of the industry. And top 3 account for around 79% of the total market share. These existing companies are making investments in several research activities to launch new devices.

Market Analysis and Insights: Global Spinal Cord Stimulation (SCS) Devices Market
In 2020, the global Spinal Cord Stimulation (SCS) Devices market size was US$ 2350.5 million and it is expected to reach US$ 3680.9 million by the end of 2027, with a CAGR of 6.6% during 2021-2027.
Global Spinal Cord Stimulation (SCS) Devices Scope and Market Size
Spinal Cord Stimulation (SCS) Devices market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Spinal Cord Stimulation (SCS) Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.


Segment by Type, the Spinal Cord Stimulation (SCS) Devices market is segmented into
Rechargeable SCS
Non-Rechargeable SCS


Segment by Application, the Spinal Cord Stimulation (SCS) Devices market is segmented into
Hospitals
Ambulatory Surgery Centers

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Spinal Cord Stimulation (SCS) Devices Market Share Analysis
Spinal Cord Stimulation (SCS) Devices market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Spinal Cord Stimulation (SCS) Devices product introduction, recent developments, Spinal Cord Stimulation (SCS) Devices sales by region, type, application and by sales channel.

The major companies include:
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra